Brief: Accelerate Diagnostics Announces Agreements To Exchange ~$51 Million In Principal Amount Of Its 2.50% Convertible Senior Notes Due 2023 For Common Stock
23/09/2021 14:30
Sept 23 (Reuters) - Accelerate Diagnostics Inc AXDX.O :
* ACCELERATE DIAGNOSTICS ANNOUNCES AGREEMENTS TO EXCHANGE
APPROXIMATELY $51 MILLION IN PRINCIPAL AMOUNT OF ITS 2.50%
CONVERTIBLE SENIOR NOTES DUE 2023 FOR COMMON STOCK
Source text for Eikon: ID:nPn4bdLrga
Further company coverage: AXDX.O
Recent news on Accelerate Diagnostics
See all newsBrief: Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets
Brief: Accelerate Diagnostics files for Chapter 11 bankruptcy
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview
Accelerate Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview